These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


581 related items for PubMed ID: 19321308

  • 1. Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1).
    Danner N, Julkunen P, Khyuppenen J, Hukkanen T, Könönen M, Säisänen L, Koskenkorva P, Vanninen R, Lehesjoki AE, Kälviäinen R, Mervaala E.
    Epilepsy Res; 2009 Jul; 85(1):81-8. PubMed ID: 19321308
    [Abstract] [Full Text] [Related]

  • 2. TMS-EEG reveals impaired intracortical interactions and coherence in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1).
    Julkunen P, Säisänen L, Könönen M, Vanninen R, Kälviäinen R, Mervaala E.
    Epilepsy Res; 2013 Sep; 106(1-2):103-12. PubMed ID: 23642573
    [Abstract] [Full Text] [Related]

  • 3. Motor cortical plasticity is impaired in Unverricht-Lundborg disease.
    Danner N, Säisänen L, Määttä S, Julkunen P, Hukkanen T, Könönen M, Hyppönen J, Kälviäinen R, Mervaala E.
    Mov Disord; 2011 Sep; 26(11):2095-100. PubMed ID: 21661050
    [Abstract] [Full Text] [Related]

  • 4. Alterations of motor cortical excitability and anatomy in Unverricht-Lundborg disease.
    Danner N, Julkunen P, Hyppönen J, Niskanen E, Säisänen L, Könönen M, Koskenkorva P, Vanninen R, Kälviäinen R, Mervaala E.
    Mov Disord; 2013 Nov; 28(13):1860-7. PubMed ID: 23925991
    [Abstract] [Full Text] [Related]

  • 5. Recruitment of motor cortex inhibition differentiates between generalized and focal epilepsy.
    Klimpe S, Behrang-Nia M, Bott MC, Werhahn KJ.
    Epilepsy Res; 2009 Apr; 84(2-3):210-6. PubMed ID: 19286351
    [Abstract] [Full Text] [Related]

  • 6. Motor cortex and thalamic atrophy in Unverricht-Lundborg disease: voxel-based morphometric study.
    Koskenkorva P, Khyuppenen J, Niskanen E, Könönen M, Bendel P, Mervaala E, Lehesjoki AE, Kälviäinen R, Vanninen R.
    Neurology; 2009 Aug 25; 73(8):606-11. PubMed ID: 19704079
    [Abstract] [Full Text] [Related]

  • 7. Primary motor cortex alterations in a compound heterozygous form of Unverricht-Lundborg disease (EPM1).
    Danner N, Julkunen P, Könönen M, Hyppönen J, Koskenkorva P, Vanninen R, Lehesjoki AE, Kälviäinen R, Mervaala E.
    Seizure; 2011 Jan 25; 20(1):65-71. PubMed ID: 21075014
    [Abstract] [Full Text] [Related]

  • 8. Abnormal motor cortical adaptation to external stimulus in Unverricht-Lundborg disease (progressive myoclonus type 1, EPM1).
    Julkunen P, Löfberg O, Kallioniemi E, Hyppönen J, Kälviäinen R, Mervaala E.
    J Neurophysiol; 2018 Aug 01; 120(2):617-623. PubMed ID: 29742025
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing cortical silent period: optimized stimulus location, intensity and muscle contraction.
    Säisänen L, Pirinen E, Teitti S, Könönen M, Julkunen P, Määttä S, Karhu J.
    J Neurosci Methods; 2008 Mar 30; 169(1):231-8. PubMed ID: 18243329
    [Abstract] [Full Text] [Related]

  • 10. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia.
    Hanajima R, Okabe S, Terao Y, Furubayashi T, Arai N, Inomata-Terada S, Hamada M, Yugeta A, Ugawa Y.
    Clin Neurophysiol; 2008 Jun 30; 119(6):1400-7. PubMed ID: 18387338
    [Abstract] [Full Text] [Related]

  • 11. Navigated transcranial magnetic stimulation and computed electric field strength reduce stimulator-dependent differences in the motor threshold.
    Danner N, Julkunen P, Könönen M, Säisänen L, Nurkkala J, Karhu J.
    J Neurosci Methods; 2008 Sep 15; 174(1):116-22. PubMed ID: 18662721
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms and dynamics of cortical motor inhibition in the stop-signal paradigm: a TMS study.
    van den Wildenberg WP, Burle B, Vidal F, van der Molen MW, Ridderinkhof KR, Hasbroucq T.
    J Cogn Neurosci; 2010 Feb 15; 22(2):225-39. PubMed ID: 19400674
    [Abstract] [Full Text] [Related]

  • 13. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.
    Hyppönen J, Äikiä M, Joensuu T, Julkunen P, Danner N, Koskenkorva P, Vanninen R, Lehesjoki AE, Mervaala E, Kälviäinen R.
    Neurology; 2015 Apr 14; 84(15):1529-36. PubMed ID: 25770194
    [Abstract] [Full Text] [Related]

  • 14. Comparison of navigated and non-navigated transcranial magnetic stimulation for motor cortex mapping, motor threshold and motor evoked potentials.
    Julkunen P, Säisänen L, Danner N, Niskanen E, Hukkanen T, Mervaala E, Könönen M.
    Neuroimage; 2009 Feb 01; 44(3):790-5. PubMed ID: 18976714
    [Abstract] [Full Text] [Related]

  • 15. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
    Vucic S, Kiernan MC.
    Brain; 2006 Sep 01; 129(Pt 9):2436-46. PubMed ID: 16835248
    [Abstract] [Full Text] [Related]

  • 16. Negative myoclonus induced by cortical electrical stimulation in epileptic patients.
    Rubboli G, Mai R, Meletti S, Francione S, Cardinale F, Tassi L, Lo Russo G, Stanzani-Maserati M, Cantalupo G, Tassinari CA.
    Brain; 2006 Jan 01; 129(Pt 1):65-81. PubMed ID: 16272166
    [Abstract] [Full Text] [Related]

  • 17. Normal cortical excitability in Myoclonus-Dystonia--a TMS study.
    van der Salm SM, van Rootselaar AF, Foncke EM, Koelman JH, Bour LJ, Bhatia KP, Rothwell JC, Tijssen MA.
    Exp Neurol; 2009 Apr 01; 216(2):300-5. PubMed ID: 19118553
    [Abstract] [Full Text] [Related]

  • 18. Lack of activation of human secondary somatosensory cortex in Unverricht-Lundborg type of progressive myoclonus epilepsy.
    Forss N, Silén T, Karjalainen T.
    Ann Neurol; 2001 Jan 01; 49(1):90-7. PubMed ID: 11198301
    [Abstract] [Full Text] [Related]

  • 19. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients.
    Cantello R, Tarletti R, Varrasi C, Cecchin M, Monaco F.
    Neuroscience; 2007 Nov 30; 150(1):64-71. PubMed ID: 17964730
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of cortical excitation and inhibition using transcranial magnetic stimulation].
    Uozumi T.
    Rinsho Shinkeigaku; 1995 Dec 30; 35(12):1512-4. PubMed ID: 8752448
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.